Home / FDA Issues Form 483 to Biocon in Bengaluru, India

FDA Issues Form 483 to Biocon in Bengaluru, India

According to Business Standard, the United States Food and Drug Administration (FDA) issued a Form 483 to Biocon regarding its plant in Bengaluru, Karnataka, India.

Recent Global Disruptions

EIGHTEENTH UPDATE: Supply Chain Disruptions Continue as Coronavirus Outbreak Worsens

Fire Engulfs Truck Carrying Fiat Spare Parts in Canapi, Sertao Alagoano, Brazil

Lactalis to Close its Milk Facility in Rockhampton, Queensland, Australia